Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA)

Int J Cardiol. 2018 Sep 15:267:41-45. doi: 10.1016/j.ijcard.2018.03.092.

Abstract

Objective: To assess the characteristics and prognosis of patients with myocardial infarction and non-obstructed coronary arteries (MINOCA).

Methods: MINOCA was defined as acute myocardial infarction (AMI) with angiographic coronary stenosis <50%.Cardiomyopathies and myocarditis were - a priori - excluded from the study. Stenoses <30% were considered normal coronary arteries (NCA); stenoses ≥30% but <50% were considered mild coronary artery disease (MCAD). Patients were subdivided in 3 groups: I) NCA (0 vessels; stenosis <30%); II) 1-2 vessels showing MCAD and III) MCAD in 3 vessels or the left main stem (LMS).

Results: From January 2006 to December 2014, 7935 consecutive AMI patients were entered into our institutional database;150 (2%) were diagnosed as having MINOCA. At a median follow-up of 7.1 years the composite end-point (cardiovascular death, AMI or acute coronary syndrome, heart failure, stroke) occurred in 23 patients (17.4%). Survival analysis showed no differences between NCA versus MCAD (p = 0.781). When assessed by distribution of CAD, group III had a lower event-free survival compared to group I and group II, respectively 54 ± 14%, 83 ± 4% and 90 ± 5% (p = 0.001). In a multivariate model, only 3 vessel disease or LMS involvement (HR = 23.5, 95% CI 2.59-173.49, P = 0.001) and high C-reactive protein at hospital admission (HR = 1.47, 95% CI 1.06-2.07, P = 0.005) were significant predictors of the study composite endpoint.

Conclusions: In patients with MINOCA, the presence of NCA or 1-2 vessel MCAD was associated with better long-term clinical outcomes compared with patients with MCAD affecting 3 vessels or the LMS. Increased CRP concentrations on hospital admission were also a marker of worse clinical outcome during follow-up.

Keywords: Acute coronary syndrome; Acute myocardial infarction; C-reactive protein; MINOCA; Prognosis.

MeSH terms

  • Aged
  • Biomarkers / analysis
  • C-Reactive Protein / analysis
  • Cause of Death
  • Coronary Angiography / methods
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / diagnosis
  • Coronary Artery Disease* / physiopathology
  • Coronary Occlusion* / diagnosis
  • Coronary Occlusion* / diagnostic imaging
  • Coronary Vessels / diagnostic imaging*
  • Female
  • Follow-Up Studies
  • Heart Failure / epidemiology
  • Heart Failure / etiology
  • Humans
  • Italy / epidemiology
  • Long Term Adverse Effects / epidemiology
  • Long Term Adverse Effects / etiology
  • Male
  • Middle Aged
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / etiology
  • Myocardial Infarction* / mortality
  • Outcome Assessment, Health Care
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Severity of Illness Index
  • Stroke / epidemiology
  • Stroke / etiology
  • Survival Analysis

Substances

  • Biomarkers
  • C-Reactive Protein